Researchers led by the University of Ulsan College of Medicine, Korea, have checked the performance of a noninvasive urinary ...

The following is a summary of “Oakland score to identify low-risk patients with lower gastrointestinal bleeding performs well among emergency department patients,” published in the February 2025 issue ...

A urinary DNA methylation test demonstrated a high sensitivity for detecting high-grade or invasive bladder cancer, ...

Investigators assessed whether MRI alone can identify all cases of Gleason grade group 2 or higher disease in patients on ...

HealthDay News — A blood-based test (Freenome) may provide a new option for colorectal cancer (CRC) screening in the average-risk U.S. population, according to a study presented at the American ...

EHAB appears substantially undervalued, taking into account the company's cash flow and positive net income. This implies higher stock price valuations ...

Artificial intelligence is altering how insurance risks are being assessed, premiums defined and claims managed.

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today commented on recent updates by the NCCN on circulating tumor DNA (ctDNA) molecular residual disease (MRD) ...

Lung ultrasound (LUS) may be an effective screening tool for interstitial lung disease in patients with asymptomatic rheumatoid arthritis.

Recent study results show that the single-target DNA methylation test performed with a negative predictive value of 97.6 percent.